Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Kim

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysisDavid E Cohn, Kenneth H Kim, Kimberly E Resnick, et al.
Gynecologic Oncology|June 4, 2020
The 2020 SGO Annual Meeting ReportKenneth H Kim, Kathleen N Moore, Rebecca C Arend, et al.
Journal of Gynecologic Oncology|January 20, 2021
Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculumTeresa K L Boitano, Haller J Smith, Joshua G Cohen, et al.
Clinical Therapeutics|February 23, 2016
Cervical Cancer in Women Aged 35 Years and YoungerElizabeth Pelkofski, Jessica Stine, Nolan A Wages, et al.
Gynecologic Oncology|November 30, 2016
Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complicationsStephanie A Sullivan, Leslie H Clark, Allison S Staley, et al.
Gynecologic Oncology|March 15, 2017
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trialWeiya Z Wysham, Elisabeth M Schaffer, Theresa Coles, et al.
Journal of Lower Genital Tract Disease|August 1, 2018
The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical CancerT Clark Powell, Sarah E Dilley, Sejong Bae, et al.
The Journal of Obstetrics and Gynaecology Research|March 12, 2026
Family Planning and Parental Leave in Obstetrics and Gynecology Fellowships: A Nation-Wide Survey of Fellows and Program Directors in the United StatesKhrystyna Levytska, Shu-Fan Chen, Victoria R Cerda, et al.
Gynecologic Oncology|April 9, 2016
Extremes in body mass index affect overall survival in women with cervical cancerLeslie H Clark, Amanda L Jackson, Adrianne E Soo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2016
Does the Robotic Platform Reduce Morbidity Associated With Combined Radical Surgery and Adjuvant Radiation for Early Cervical Cancers?Leslie H Clark, Emma L Barber, Paola A Gehrig, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysisDavid E Cohn, Kenneth H Kim, Kimberly E Resnick, et al.
Gynecologic Oncology|June 4, 2020
The 2020 SGO Annual Meeting ReportKenneth H Kim, Kathleen N Moore, Rebecca C Arend, et al.
Journal of Gynecologic Oncology|January 20, 2021
Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculumTeresa K L Boitano, Haller J Smith, Joshua G Cohen, et al.
Clinical Therapeutics|February 23, 2016
Cervical Cancer in Women Aged 35 Years and YoungerElizabeth Pelkofski, Jessica Stine, Nolan A Wages, et al.
Gynecologic Oncology|November 30, 2016
Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complicationsStephanie A Sullivan, Leslie H Clark, Allison S Staley, et al.
Gynecologic Oncology|March 15, 2017
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trialWeiya Z Wysham, Elisabeth M Schaffer, Theresa Coles, et al.
Journal of Lower Genital Tract Disease|August 1, 2018
The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical CancerT Clark Powell, Sarah E Dilley, Sejong Bae, et al.
The Journal of Obstetrics and Gynaecology Research|March 12, 2026
Family Planning and Parental Leave in Obstetrics and Gynecology Fellowships: A Nation-Wide Survey of Fellows and Program Directors in the United StatesKhrystyna Levytska, Shu-Fan Chen, Victoria R Cerda, et al.
Gynecologic Oncology|April 9, 2016
Extremes in body mass index affect overall survival in women with cervical cancerLeslie H Clark, Amanda L Jackson, Adrianne E Soo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2016
Does the Robotic Platform Reduce Morbidity Associated With Combined Radical Surgery and Adjuvant Radiation for Early Cervical Cancers?Leslie H Clark, Emma L Barber, Paola A Gehrig, et al.
Pageof 7